UBS Group AG - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$2,399
-93.6%
475
-93.7%
0.00%
Q2 2023$37,725
+135.9%
7,500
+188.5%
0.00%
Q1 2023$15,990
-46.7%
2,600
-73.7%
0.00%
Q3 2022$30,000
+100.0%
9,883
+295.5%
0.00%
Q1 2022$15,000
-65.9%
2,499
-15.2%
0.00%
Q3 2021$44,000
-80.4%
2,946
-97.2%
0.00%
Q4 2020$224,000
-7.1%
104,890
+1.3%
0.00%
Q3 2020$241,000
+760.7%
103,579
+169.7%
0.00%
Q1 2020$28,000
+100.0%
38,400
+604.6%
0.00%
Q4 2019$14,000
+55.6%
5,450
+244.3%
0.00%
Q2 2019$9,0001,5830.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q1 2022
NameSharesValueWeighting ↓
INSPIRION WEALTH ADVISORS, LLC 330,874$1,670,9140.33%
TANG CAPITAL MANAGEMENT LLC 400,000$2,020,0000.28%
AMUSSEN HUNSAKER ASSOCIATES LLC 75,016$377,3300.08%
Nebula Research & Development LLC 25,708$129,8250.07%
Corton Capital Inc. 22,091$111,5600.06%
Sofinnova Investments, Inc. 142,635$720,3070.04%
LAZARI CAPITAL MANAGEMENT, INC. 11,000$55,5500.03%
OCCUDO QUANTITATIVE STRATEGIES LP 24,369$123,0630.02%
WINTON GROUP Ltd 21,256$107,3430.01%
Truvestments Capital LLC 1,372$6,9290.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders